wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37958741-0E27C10F-D1D8-468E-A97F-3DDCBA0E749F
Q37958741-0E27C10F-D1D8-468E-A97F-3DDCBA0E749F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37958741-0E27C10F-D1D8-468E-A97F-3DDCBA0E749F
Novel options for the treatment of castration-resistant prostate cancer.
P2860
Q37958741-0E27C10F-D1D8-468E-A97F-3DDCBA0E749F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37958741-0E27C10F-D1D8-468E-A97F-3DDCBA0E749F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fce0509d5c4fc98b1a4687d87f310b5ac565ba79
P2860
A multicenter phase II study of XRP6258 administered as a 1-h i.v. infusion every 3 weeks in taxane-resistant metastatic breast cancer patients.